Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Change in Inventory (2020 - 2025)

Zai Lab (ZLAB) has disclosed Change in Inventory for 6 consecutive years, with $18.9 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 3630.97% to $18.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $47.0 million through Dec 2025, up 1307.08% year-over-year, with the annual reading at $47.0 million for FY2025, 1307.08% up from the prior year.
  • Change in Inventory hit $18.9 million in Q4 2025 for Zai Lab, up from $6.0 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $18.9 million in Q4 2025 to a low of -$6.8 million in Q1 2024.
  • Historically, Change in Inventory has averaged $4.0 million across 5 years, with a median of $2.6 million in 2022.
  • Biggest five-year swings in Change in Inventory: crashed 1215.56% in 2021 and later skyrocketed 8203.39% in 2024.
  • Year by year, Change in Inventory stood at $7.4 million in 2021, then crashed by 71.07% to $2.1 million in 2022, then tumbled by 76.76% to $499000.0 in 2023, then grew by 1.6% to $507000.0 in 2024, then surged by 3630.97% to $18.9 million in 2025.
  • Business Quant data shows Change in Inventory for ZLAB at $18.9 million in Q4 2025, $6.0 million in Q3 2025, and $8.9 million in Q2 2025.